QHSLab Inc · OTC:USAQ
QHSLab — Investor Presentation (January 2025)
29 slides from QHSLab's investor presentation, Jan 21, 2025
Slide 1: Empowering Healthcare Through Digital Medicine
G GHSLAB Empowering Healthcare Through Digital Medicine Innovation Revolutionizing Primary Care: New Vision. New Opportunities. QHSLab.com Stock Symbol: USAQ Corporate Presentation - January 2025
Slide 2: Forward-Looking Statements & Disclaimers
CG QGHSLAB Forward-Looking Statements & Disclaimers This presentation contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21€ of the Securities Exchange Act of 1934, as amended, Statements in this presentat
Slide 3: Key Takeaways for Investment
Cy GHSLAB Key Takeaways for Investment Revenue Producing: QHSLab's business model generates recurring revenue for the company itself and its medical practitioner clients. This revenue comes from a large and continuously expanding addressable end market. Positioned for Growth: We are favorably aligne
Slide 4: Financial Turnaround: From Loss to Profit with 38% Revenue Growth
CG QHSLAB Financial Turnaround: From Loss to Profit with 38% Revenue Growth Bi Revenue [ll Gross Profit 2000000 Building on a record-breaking year of robust revenue growth and enhanced profitability, QHSLab is primed for exponential expansion. 1500000 Strategic investment will amplify market penetra
Slide 5: Path to Profitability
Cy QHSLAB Path to Profitability Revenue Growth: + Revenue jumped 38% year-over-year, reaching $1.51M for the first nine months of 2024. + This growth reflects the increasing adoption of our solutions and a strong market presence. Profitability Milestone: + After years of investment, QHSLab achieved
Slide 6: Highly-Profitable Business Model
CG QHSLAB Highly-Profitable Business Model Our scalable and straightforward business model enables providers to deliver better care while generating additional revenue. Here’s how our key revenue streams break down: Allergy Diagnostic Kits: $100 per test — $12,000 annually per provider Immunotherapy
Slide 7: Leveraging Our Strengths & Competitive Advantages
CG QGHSLAB Leveraging Our Strengths & Competitive Advantages Product Profile: Exclusive product line featuring FDA-cleared diagnostic equipment, widely accepted by Medicare and private insurance providers. Advanced Technology Platform: The QHSLab Expert System efficiently processes large volumes of
Slide 8: Vision and Execution: Transforming Primary Care
CG QGHSLAB Vision and Execution: Transforming Primary Care Our Dedication: To revolutionize patient care through well-integrated programs not only sets new industry standards but also positively impacts the overall well-being of patients. Our Mission: To improve the quality of life for individuals a
Slide 9: The Problem: Primary care gaps are failing millions of patients
Cy QGHSLAB The Problem: Primary care gaps are failing millions of patients, driving untreated conditions and worsening outcomes. Doctor Lack Time and Tools: 18 minutes* per patient visit —too short for comprehensive care. 40%** of mental health issues and 50% of allergy symptoms go undiagnosed. csou
Slide 10: The True Cost of Gaps in Primary Care
CG QGHSLAB The True Cost of Gaps in Primary Care: Too Many Patients, Too Little Time leading to Overwhelmed Providers, Underserved Patients. Untreated Conditions Escalate: Millions of undiagnosed and poorly managed conditions lead to preventable complications and chronic illnesses. Quality of Care F
Slide 11: Intelligent Tools & Patient-Centric Health Care Technologies for Smarter Primary Care
CG QHSLAB Intelligent Tools & Patient-Centric Health Care Technologies for Smarter Primary Care Advanced Patient Engagement: Interactive digital tools collect meaningful data from patients, uncovering hidden symptoms Data-Driven Insights: Robust back-end organizes patient input into actionable insig
Slide 12: Transforming Patient Data into Clinical Insights and Better Health Outcomes
Cy QHSLAB Transforming Patient Data into Cl Outcomes ge ‘al Insights and Better Health Our Mission: Improving quality of life through physician-directed digital health and innovative point-of- care solutions. Our Goals: + Enhance patient outcomes. + Reduce clinical workload while enabling practition
Slide 13: Empowering Providers and Patients with Intelligent, Reimbursable Solutions
Mastering Back Pain Partt Video o rary EatWell Diabetes © AppStore G QHSLAB Empowering Providers and Patients with Intelligent, Reimbursable Solutions What It Does: ‘A cloud-based software that engages patients, uncovers hidden conditions, and empowers physicians with actionable insights. Why It Mat
Slide 14: Integrating Mental Health & Allergic Disease Management
CG QHSLAB Integrating Mental Health & Allergic Disease Management The Connection: Allergies significantly impact mental health, work productivity, and overall well- being. Patients with allergies are more likely to experience depression and anxiety. Key Insights: Hay fever sufferers have a 1.6x high
Slide 15: Q-Scale: Mental Health Insights for Better Care
(~=-) CG QHSLAB CoH Q-Scale: Mental Health Insights for Better Care What It Does: The Q-Scale measures patients’ quality of life across sleep, stress, anxiety, pain, and overall life satisfaction. Identifies high-risk mental health concerns for early intervention. How It Works: CO 10-item questionna
Slide 16: The Demand for Mental Healthcare Grows
CG QGHSLAB The Demand for Mental Healthcare Grows Adults with medical illnesses are more likely to experience depression, and those with depression face a higher risk of chronic diseases. Chronic conditions affect 6 in 10 Americans, driving $4.1 trillion in annual healthcare costs. Mental health is
Slide 17: Allergy: Key Products, Features and Proven Impact
CG QGHSLAB Allergy: Key Products, Features and Proven Impact Proven Impact: Serves a massive market: Over 150M Americans suffer from allergies, costing $1 6B annually in OTC and prescription treatments, by simplifying allergy care, QHSLab enables primary care providers to treat their patients, makin
Slide 18: Addressing Allergies and Mental Health
Cy GHSLAB Addressing Allergies and Mental Health Enhanced Patient Care: Integrating allergy testing and treatment with mental health programs in primary care enables comprehensive patient care, improving outcomes and well-being by addressing physical and mental health needs. Streamlined Workflow: In
Slide 19: Market Opportunity and Growth Potential
CG QHSLAB Market Opportunity and Growth Potential TAM (Total Addressable Market) + Mental Health Market: $109B in 2023, projected to reach $167B by 2032. + Allergy Testing Market: Rapid growth driven by increasing demand for in-office SOM: $508 diagnostic solutions. SAM (Serviceable Available Market
Slide 20: Competitive Landscape: QHSLab's Unique Position in Mental Health and Allergy Solutions
CG QGHSLAB Competitive Landscape: QHSLab's Unique Position in Mental Health and Allergy Solutions Mental Health Assessments: 1. Competitors: Online tools like Kaiser Permanente’s Mental Health Care Hub, and standalone platforms such as BetterHelp and Talkspace. 2. Challenges for Competitors: 1.Lack
Slide 21: QHSLab's Unique Differentiators
Cy QHSLAB 5 QHSLab’s: Unique Differentiators J Comprehensive Suite: Combines mental health and allergy solutions in one platform, streamlining care for primary practices. Reimbursable Tools: Services align with CPT codes, ensuring seamless insurance reimbursement. Accessibility: Makes high-quality d
Slide 22: Addressing Challenges: Building a Stronger Future
{ Cy GHSLAB Addressing Challenges: Building a Stronger Future Acknowledging the Past Growth has been slower due to a deliberate focus on achieving product-market fit and navigating financial constraints, including managing convertible debt. Current Readiness QHSLab’s products are now clinically vali
Slide 23: Path Forward: Unlocking Growth with Strategic Investment
CG QHSLAB Path Forward: Unlocking Growth with Strategic Investment With a clear foundation in place, new investments will directly accelerate QHSLab's growth by addressing key priorities: Eliminate Convertible Debt: Free up cash flow to invest in scaling operations and expanding our reach. Expand Sa
Slide 24: Benefits to Doctors That Drive QHSLab's Revenue
Cy QGHSLAB Benefits to Doctors That Drive QHSLab's Revenue Annual Revenue ($M) 10 50 150 Number of Physicians 300 Empowering Physicians, Driving Revenue Nearly 50% of primary care physicians (~250,000) are independent, handling over 52% of all physician office visits. Innovative Solutions QHSLab’s s
Slide 25: Positioned for Growth In a Changing Healthcare Landscape
/ \ Cy GHSLAB Positioned for Growth In a Changing Healthcare Landscape Allergy Care Gap: 60 million Americans suffer from allergic disorders, with fewer than 3,000 practicing allergists. Demand for allergy services is expected to rise by 35%, while the number of allergists is declining. Telemedicine
Slide 26: Operational Excellence that Driving Growth and Visibility
CG QHSLAB Operational Excellence that Driving Growth and Visibility Expanding Recurring Revenue: Growing adoption of point-of-care and digital medicine services to boost revenue per client and exploring partnerships with MSOs, IPAs, and distributors to scale operations. Integration with electronic h
Slide 27: Expanding Our Presence and Thought Leadership
QHSLAB Expanding Our Presence and Thought Leadership ‘Allergy Diagnostics & ‘Allergen immunotherapy Workshop GHS) lan Sanain corpore sano”: -AGlinical Perspective on The Bidirectional Relationship Between ‘Mental and Physical Health Corporate Presentation - January 2025
Slide 28: Executive Leadership Team
Executive Leadership Team € ~] JEREMY JACOB, CHIEF TECHNOLOGY OFFICER: With over two decades of experience, Jeremy has honed his , technical expertise in crafting cuting edge solutions centered around scalable cloud technology. He has an Impressive track record of designing and launching innovative
Slide 29: General Inquiries
General Inquiries [email protected] Investor Relations [email protected] QHSLab, Inc. 901 Northpoint Parkway Suite 302, West Palm Beach, FL 33407 www.usaqcorp.com Corporate Presentation - January 2025